[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Tetracaine.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Idecabtagene vicleucel.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Benzocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Benzyl alcohol.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Bupivacaine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Oxybuprocaine.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Capsaicin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Chloroprocaine.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Dyclonine.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Levobupivacaine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Cocaine.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Idecabtagene vicleucel.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Cinchocaine.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Pramocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Diphenhydramine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Ropivacaine.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Etidocaine.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Articaine.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Lidocaine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Mepivacaine.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Idecabtagene vicleucel.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Prilocaine.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Procaine.]
